ViroStatics acquires library of 300 drug compounds from University of Siena
The library consists of specifically designed molecules targeting key enzymes and processes involved in both cancer and viral diseases. ViroStatics will identify and develop candidate compounds with activity
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.